e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Understanding new vaccines for SARS-CoV-2 and their regulation
A. Simonds (London, United Kingdom), T. Welte (Hannover, Germany), M. Cavaleri (Amsterdam, Netherlands), R. Boyton (London, United Kingdom)
Source:
ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation
Number:
0
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Simonds (London, United Kingdom), T. Welte (Hannover, Germany), M. Cavaleri (Amsterdam, Netherlands), R. Boyton (London, United Kingdom). Understanding new vaccines for SARS-CoV-2 and their regulation. ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Bipen Patel - 05.02.2021 16:40
Excellent, but almost too much information to assimilate in the time allowed.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS statement on long COVID-19 follow-up
Occupational COVID-19
TB and COVID-19 – a dangerous new combination?
Related content which might interest you:
COVID-19 vaccination and more
Source: ERS webinar 2021: COVID-19 vaccination and more
Year: 2021
Medical staff attitude to vaccination against an influenza virus
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Seasonal influenza vaccine effectiveness in people with asthma: A systematic review
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Development of RSV vaccines: where are we?
Source: International Congress 2019 – Respiratory syncytial virus infections throughout life
Year: 2019
New Influenza vaccines
Source: Virtual Congress 2021 – Vaccination and infections
Year: 2021
New treatments for RSV and other viruses, including update on vaccines
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Age and impact of vaccine on seasonal H1N1p severe infection
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Rapid spread of the novel respiratory syncytial virus A ON1 genotype, during the epidemic seasons 2011-2013
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014
The first H7N9 influenza case of Shanghai in 2014: Reemerged virus with different origin of PB2 gene
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
SARS-CoV-2 (COVID-19): Research response
Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response
Year: 2020
State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012
ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Year: 2020
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Year: 2020
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Year: 2020
Influenza: vaccination and treatment
Source: Eur Respir J 2001; 17: 1282-1293
Year: 2001
Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Pneumococcal vaccine: when, what, how and to whom
Source: International Congress 2014 – MS06 What's new in pneumococcal vaccination?
Year: 2014
Interview on Coronavirus COVID-19 management experience in China
Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China
Year: 2020
Clinical and epidemiological features in H1N1 and H3N2 influenza A virus
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Ebola: progress with vaccines
Source: International Congress 2015 – Pandemics and emerging infections
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept